Key result
Patenting and licensing practices influence regional HPV vaccine manufacturing in India, impacting affordability and access.
Key points are not available for this paper at this time.
May constrain HPV vaccine access in India; leaves open optimal IP policies for global manufacturing equity.
An empirical study of the impact of patenting and licensing on regional manufacturing of human papilloma virus vaccines to help improve vaccine affordability and access.
No takes yet. Share an insight, caveat, or question.
Padmanabhan et al. (2010) studied this question. Patenting and licensing practices influence the regional manufacturing of human papillomavirus vaccines in India, affecting overall vaccine affordability and access.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: